| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 7, 2025 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 26,139 | $1.50 | $39,156.22 | -3.4% | -8.6% | +28.5% | |
| Mar 7, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya81 | Chief Executive Officer | Sell | 29,722 | $4.12 | $122,454.64 | -3.3% | -63.0% | -55.3% | |
| Mar 7, 2025 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 12,691 | $10.64 | $135,032.24 | -0.2% | +18.9% | +17.0% | |
| Mar 7, 2025 | CERS Cerus Corp | Jensen Chrystal71 | Chief Legal Officer | Sell | 27,457 | $1.50 | $41,130.59 | -3.2% | -8.6% | +28.5% | |
| Mar 7, 2025 | CERS Cerus Corp | Jayaraman Vivek K67 | Chief Operating Officer | Sell | 33,999 | $1.50 | $50,930.50 | -2.2% | -8.6% | +28.5% | |
| Mar 6, 2025 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 3,662 | $61.31 | $224,517.22 | -3.3% | +1.7% | -60.0% | |
| Mar 6, 2025 | AORT Artivion, Inc. | Stanton Marshall S. | SVP, Clinical &MD Affair | Sell | 1,603 | $24.80 | $39,761.13 | -1.4% | +16.0% | +49.9% | |
| Mar 6, 2025 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 3,588 | $61.31 | $219,980.28 | -5.4% | +1.7% | -60.0% | |
| Mar 6, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 2,618 | $24.80 | $64,938.70 | -1.2% | +16.0% | +49.9% | |
| Mar 6, 2025 | AORT Artivion, Inc. | Berry Lance A | Executive VP, CFO | Sell | 4,909 | $24.80 | $121,763.82 | -3.1% | +16.0% | +49.9% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Mirza Mansoor Raza79 | Director | Sell | 99 | $4.16 | $411.84 | -0.2% | -59.0% | -53.5% | |
| Mar 6, 2025 | AVNS Avanos Medical, Inc. | Holbrook Kerr | SVP, Chief Commercial Officer | Sell | 7,000 | $15.25 | $106,778.00 | -7.9% | -18.1% | -12.7% | |
| Mar 6, 2025 | AORT Artivion, Inc. | MacKin James P53 | President &CEO | Sell | 88,439 | $24.77 | $2,190,848.33 | -4.9% | +16.0% | +49.9% | |
| Mar 6, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 2,124 | $24.80 | $52,685.40 | -1.1% | +16.0% | +49.9% | |
| Mar 6, 2025 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 15,916 | $61.31 | $975,809.96 | -8.2% | +1.7% | -60.0% | |
| Mar 6, 2025 | PRCT Procept Biorobotics Corp | Nouri Alaleh50 | EVP, CLO, Corp. Sec. | Sell | 3,641 | $61.31 | $223,229.71 | -5.6% | +1.7% | -60.0% | |
| Mar 6, 2025 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 1,048 | $24.80 | $25,995.01 | -0.7% | +16.0% | +49.9% | |
| Mar 6, 2025 | RCEL Avita Medical, Inc. | McNamara Robert | Director | Buy | 11,000 | $8.30 | $91,300.00 | +24.0% | -28.3% | -42.3% | |
| Mar 6, 2025 | ATEC Alphatec Holdings, Inc. | Sponsel David61 | EVP, Sales | Sell | 33,732 | $10.83 | $365,317.56 | -4.8% | +13.7% | +13.3% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin83 | General Counsel | Sell | 2,285 | $4.16 | $9,505.60 | -1.6% | -59.0% | -53.5% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul81 | Chief Data Officer | Sell | 1,338 | $4.16 | $5,566.08 | -0.7% | -59.0% | -53.5% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Boniface John J.56 | Chief Scientific Officer | Sell | 2,044 | $4.16 | $8,503.04 | -1.2% | -59.0% | -53.5% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner76 | Chief Information Officer | Sell | 3,251 | $4.16 | $13,524.16 | -2.5% | -59.0% | -53.5% | |
| Mar 6, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin82 | Chief Financial Officer | Sell | 540 | $4.16 | $2,246.40 | -0.2% | -59.0% | -53.5% | |
| Mar 6, 2025 | ISRG Intuitive Surgical Inc | Brosius Mark56 | SVP &Chief Mfg And Supply Cha | Sell | 1,476 | $558.94 | $824,990.52 | -13.8% | +3.6% | -9.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.